Aurobindo biologics arm CuraTeQ secures Health Canada nod for Dyrupeg

January 9, 2026
Uncategorized

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received Health Canada’s Notice of Compliance for Dyrupeg, marking a major regulatory milestone for its biologics portfolio.

Aurobindo biologics arm CuraTeQ secures Health Canada nod for Dyrupeg

Leave a ReplyCancel Reply

Airbus beats aircraft delivery goal after late December rally

Ahead of IPO, Amagi Media Labs mobilises ₹805 cr from anchor investors

Apple and Google confirm multiyear deal for AI technology, Siri

Tata Steel secures interim relief extension in ₹1,900 crore and ₹2,410 crore demand matters

Former US Fed chairs, policymakers decry ‘unprecedented’ Trump assault on Powell